GILEAD SCIENCES, INC. — Director's Dealing 2017

Oct 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-10-02

Reporting Person: MARTIN JOHN C (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-02	Common Stock	M	73333	$21.575	Acquired	3070099	Direct
2017-10-02	Common Stock	S	5200	$81.82	Disposed	3064899	Direct
2017-10-02	Common Stock	S	68133	$82.6157	Disposed	2996766	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-02	Non-qualified Stock Option (Right to Buy)	$21.575	M	73333	Disposed	2018-01-30	Common Stock (73333)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $81.26 to $82.25. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $82.27 to $82.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.